Table 1.
The baseline characteristics of participants classified by the value of TyG index
| T1 | T2 | T3 | P value | |
|---|---|---|---|---|
| N | 2038 | 2038 | 2038 | |
| TyG index | 8.01 (0.25) | 8.58 (0.15) | 9.38 (0.49) | < 0.001 |
| TG/HDL-C | 1.17 (0.45) | 2.18 (0.76) | 5.98 (5.67) | < 0.001 |
| TG/HDL-C (%) | < 0.001 | |||
| Q1 | 1637 (80.3) | 385 (18.9) | 16 (0.8) | |
| Q2 | 396 (19.4) | 1305 (64.0) | 337 (16.5) | |
| Q3 | 5 (0.2) | 348 (17.1) | 1685 (82.7) | |
| AGE | 57.74 (9.40) | 58.15 (8.92) | 57.72 (8.61) | 0.233 |
| Education (%) | 0.027 | |||
| Low | 967 (47.4) | 1006 (49.4) | 903 (44.3) | |
| Median | 1021 (50.1) | 983 (48.2) | 1077 (52.8) | |
| High | 50 (2.5) | 49 (2.4) | 58 (2.8) | |
| MALE (%) | 1034 (50.7) | 914 (44.8) | 828 (40.6) | < 0.001 |
| BMI | 23.70 (4.95) | 23.68 (4.91) | 23.63 (5.09) | 0.911 |
| BUN (mg/dl) | 16.17 (4.60) | 15.49 (4.22) | 15.33 (4.25) | < 0.001 |
| Glucose (mg/dl) | 96.49 (13.50) | 103.35 (15.63) | 126.32 (48.76) | < 0.001 |
| Creatinine (mg/dl) | 0.76 (0.18) | 0.77 (0.18) | 0.78 (0.20) | 0.021 |
| TC (mg/dl) | 181.32 (32.82) | 193.01 (35.92) | 205.32 (40.40) | < 0.001 |
| TG (mg/dl) | 64.89 (15.04) | 106.26 (20.06) | 217.51 (118.57) | < 0.001 |
| HDL-C (mg/dl) | 59.67 (14.96) | 52.43 (13.49) | 42.73 (12.16) | < 0.001 |
| LDL-C (mg/dl) | 110.54 (28.99) | 121.18 (33.00) | 116.79 (39.43) | < 0.001 |
| CRP (mg/l) | 2.39 (7.52) | 2.41 (6.22) | 2.52 (6.19) | 0.807 |
| Uric Acid (mg/dl) | 4.21 (1.12) | 4.33 (1.19) | 4.62 (1.30) | < 0.001 |
| eGFR | 96.7 (87.3, 104.5) | 95.7 (86.1, 103.2) | 94.3 (83.2, 102.1) | < 0.001 |
| Hypertension (%) | 409 (20.1) | 363 (17.8) | 353 (17.3) | 0.054 |
| Dyslipidemia (%) | 127 (6.2) | 143 (7.0) | 123 (6.0) | 0.401 |
| Diabetes (%) | 81 (4.0) | 86 (4.2) | 80 (3.9) | 0.877 |
| Asthma (%) | 63 (3.1) | 53 (2.6) | 56 (2.7) | 0.623 |
| Smoking (%) | 774 (38.0) | 789 (38.7) | 761 (37.3) | 0.664 |
| Drinking (%) | 679 (33.3) | 622 (30.5) | 626 (30.7) | 0.100 |
| CKD (%) | 45(2.2) | 52(2.5) | 86(4.2) | 0.021 |
| Antihypertensive (%) | 259 (12.7) | 183 (9.0) | 188 (9.2) | 0.294 |
| Antidiabetic (%) | 61 (3.0) | 56 (2.7) | 54 (2.6) | 0.196 |
| CVD in 2018 (%) | 239 (11.7) | 231 (11.3) | 283 (13.9) | 0.028 |